Parnax Lab Limited (PARNAXLAB.BO)
INR 100.05
(0.0%)
INR 100.05
(0.0%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 1.88 Billion INR | 12.59% |
| 2022 | 1.67 Billion INR | 2.81% |
| 2021 | 1.63 Billion INR | 81.03% |
| 2020 | 900.59 Million INR | -5.51% |
| 2019 | 953.14 Million INR | -12.38% |
| 2018 | 1.08 Billion INR | 3.11% |
| 2017 | 1.05 Billion INR | 11.27% |
| 2016 | 948.09 Million INR | 33.19% |
| 2015 | 711.82 Million INR | -30.72% |
| 2014 | 1.02 Billion INR | 49.83% |
| 2013 | 685.73 Million INR | 22.84% |
| 2012 | 558.21 Million INR | -40.02% |
| 2011 | 930.64 Million INR | 0.0% |
| 2010 | - INR | 0.0% |
| 2009 | - INR | 0.0% |
| 2008 | - INR | 0.0% |
| 2007 | - INR | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 501.2 Million INR | 8.09% |
| 2023 Q4 | 463.69 Million INR | -9.06% |
| 2023 Q3 | 509.88 Million INR | 19.66% |
| 2023 FY | 1.88 Billion INR | 12.59% |
| 2023 Q1 | 487.41 Million INR | 19.15% |
| 2023 Q2 | 426.11 Million INR | -12.58% |
| 2022 Q4 | 409.06 Million INR | -12.63% |
| 2022 Q2 | 431.38 Million INR | 17.42% |
| 2022 Q3 | 468.22 Million INR | 8.54% |
| 2022 FY | 1.67 Billion INR | 2.81% |
| 2022 Q1 | 367.39 Million INR | -23.32% |
| 2021 FY | 1.63 Billion INR | 81.03% |
| 2021 Q1 | 286.94 Million INR | 36.5% |
| 2021 Q2 | 357.51 Million INR | 24.59% |
| 2021 Q3 | 506.75 Million INR | 41.74% |
| 2021 Q4 | 479.11 Million INR | -5.45% |
| 2020 Q4 | 210.21 Million INR | -15.32% |
| 2020 Q2 | 267.49 Million INR | 53.19% |
| 2020 Q3 | 248.26 Million INR | -7.19% |
| 2020 FY | 900.59 Million INR | -5.51% |
| 2020 Q1 | 174.61 Million INR | -25.66% |
| 2019 Q1 | 206.63 Million INR | 2.62% |
| 2019 Q4 | 234.89 Million INR | -7.74% |
| 2019 FY | 953.14 Million INR | -12.38% |
| 2019 Q3 | 254.58 Million INR | -0.96% |
| 2019 Q2 | 257.03 Million INR | 24.39% |
| 2018 Q4 | 201.35 Million INR | -13.63% |
| 2018 Q3 | 233.12 Million INR | -44.85% |
| 2018 Q2 | 422.68 Million INR | 83.27% |
| 2018 Q1 | 230.64 Million INR | 6.49% |
| 2018 FY | 1.08 Billion INR | 3.11% |
| 2017 Q2 | 356.05 Million INR | 56.91% |
| 2017 FY | 1.05 Billion INR | 11.27% |
| 2017 Q4 | 216.57 Million INR | -13.71% |
| 2017 Q1 | 226.92 Million INR | 6.54% |
| 2017 Q3 | 250.98 Million INR | -29.51% |
| 2016 Q1 | 217.46 Million INR | 15.35% |
| 2016 FY | 948.09 Million INR | 33.19% |
| 2016 Q4 | 212.99 Million INR | -20.1% |
| 2016 Q3 | 266.57 Million INR | 6.16% |
| 2016 Q2 | 251.11 Million INR | 15.47% |
| 2015 Q1 | 162.77 Million INR | -37.35% |
| 2015 FY | 711.82 Million INR | -30.72% |
| 2015 Q3 | 174.35 Million INR | -6.35% |
| 2015 Q2 | 186.17 Million INR | 14.38% |
| 2015 Q4 | 188.52 Million INR | 8.13% |
| 2014 Q1 | 211.92 Million INR | -2.19% |
| 2014 FY | 1.02 Billion INR | 49.83% |
| 2014 Q3 | 286.57 Million INR | 6.47% |
| 2014 Q4 | 259.81 Million INR | -9.34% |
| 2014 Q2 | 269.15 Million INR | 27.0% |
| 2013 Q3 | 183.66 Million INR | 11.03% |
| 2013 FY | 685.73 Million INR | 22.84% |
| 2013 Q1 | 120.05 Million INR | -19.81% |
| 2013 Q2 | 165.41 Million INR | 37.78% |
| 2013 Q4 | 216.66 Million INR | 17.97% |
| 2012 Q4 | 149.72 Million INR | -6.58% |
| 2012 Q2 | 134.59 Million INR | 18.46% |
| 2012 FY | 558.21 Million INR | -40.02% |
| 2012 Q3 | 160.27 Million INR | 19.08% |
| 2012 Q1 | 113.61 Million INR | 0.0% |
| 2011 FY | 930.64 Million INR | 0.0% |
| 2010 FY | - INR | 0.0% |
| 2009 FY | - INR | 0.0% |
| 2008 FY | - INR | 0.0% |
| 2008 Q4 | - INR | 0.0% |
| 2007 FY | - INR | 0.0% |
| 2007 Q4 | - INR | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| DECIPHER LABS LIMITED | 362.75 Million INR | -420.22% |
| Gujarat Themis Biosyn Limited | 1.69 Billion INR | -11.123% |
| Ishita Drugs and Industries Limited | 151.87 Million INR | -1142.535% |
| MedPlus Health Services Limited | 56.24 Billion INR | 96.645% |
| ANG Lifesciences India Limited | 1.46 Billion INR | -29.157% |
| Add-Shop E-Retail Limited | 2.02 Billion INR | 6.618% |
| Bacil Pharma Limited | - INR | -Infinity% |
| BDH Industries Limited | 858.31 Million INR | -119.864% |
| Beryl Drugs Limited | 271.24 Million INR | -595.717% |
| Cian Healthcare Limited | 616.95 Million INR | -205.875% |
| Chemo Pharma Laboratories Limited | 18.38 Million INR | -10166.086% |
| Concord Drugs Limited | 449.24 Million INR | -320.063% |
| Deccan Health Care Limited | 597.28 Million INR | -215.946% |
| Gujarat Terce Laboratories Limited | 479.74 Million INR | -293.356% |
| Hindustan Bio Sciences Limited | 10.48 Million INR | -17890.426% |
| Jenburkt Pharmaceuticals Limited | 1.41 Billion INR | -32.927% |
| KIMIA BIOSCIENCES LIMITED | 1.04 Billion INR | -79.937% |
| Kwality Pharmaceuticals Limited | 3.07 Billion INR | 38.565% |
| Makers Laboratories Limited | 1.03 Billion INR | -81.867% |
| Medi-Caps Limited | 265.63 Million INR | -610.415% |
| Panchsheel Organics Limited | 1.05 Billion INR | -79.351% |
| Parmax Pharma Limited | 154.24 Million INR | -1123.463% |
| Patidar Buildcon Limited | 2.3 Million INR | -81663.951% |
| Phaarmasia Limited | 305.93 Million INR | -516.838% |
| Vikram Thermo (India) Limited | 1.25 Billion INR | -50.474% |
| Sanjivani Paranteral Limited. | 536.87 Million INR | -251.502% |
| SHAMROCK INDUSTRIAL CO.LTD. | 1.11 Million INR | -168693.56% |
| Smruthi Organics Limited | 1.27 Billion INR | -47.843% |
| Source Natural Foods and Herbal Supplements Limited | 272.96 Million INR | -591.331% |
| SUDARSHAN PHARMA INDUSTRIES LI | 4.63 Billion INR | 59.289% |
| Trident Lifeline Limited | 446.28 Million INR | -322.848% |
| Transchem Limited | 4.09 Million INR | -45927.133% |
| Trinity League India Limited | 2.95 Million INR | -63869.898% |
| Tyche Industries Limited | 696.83 Million INR | -170.811% |
| Vista Pharmaceuticals Limited | 102.87 Million INR | -1734.32% |
| Vivanza Biosciences Limited | 278.89 Million INR | -576.646% |
| PRAVEG LIMITED | 915.96 Million INR | -106.024% |
| Sastasundar Ventures Limited | 13.56 Billion INR | 86.084% |
| Sunil Healthcare Limited | 901.91 Million INR | -109.233% |
| Syschem (India) Limited | 2.33 Billion INR | 19.193% |
| Zenith Healthcare Limited | 144.71 Million INR | -1204.002% |
| Zenlabs Ethica Limited | 585.63 Million INR | -222.236% |
| Mercury Laboratories Limited | 755.59 Million INR | -149.753% |
| SHELTER PHARMA LIMITED | 400.22 Million INR | -371.508% |
| Vasundhara Rasayans Limited | 370.18 Million INR | -409.777% |
| Bharat Immunologicals & Biologicals Corporation Limited | 446.09 Million INR | -323.033% |
| Roopa Industries Limited | 715.53 Million INR | -163.734% |
| PANJON LTD. | 125.52 Million INR | -1403.423% |
| Pharmaids Pharmaceuticals Limited | 151.12 Million INR | -1148.742% |
| TIAAN CONSUMER LIMITED | - INR | -Infinity% |
| Anuh Pharma Limited | 6.47 Billion INR | 70.833% |
| Crestchem Limited | 212.56 Million INR | -787.794% |
| Emmessar Biotech & Nutrition Limited | 5.55 Million INR | -33889.769% |
| Sandu Pharmaceuticals Limited | 672.8 Million INR | -180.483% |
| Fredun Pharmaceuticals Limited | 3.48 Billion INR | 45.797% |
| Trimurthi Limited | 42.23 Million INR | -4367.806% |
| Shukra Pharmaceuticals Limited | 745.72 Million INR | -153.056% |
| Norris Medicines Limited | 56.35 Million INR | -3248.548% |
| Veerhealth Care Limited | 142.13 Million INR | -1227.699% |
| Lactose (India) Limited | 1.13 Billion INR | -65.696% |
| OXYGENTA PHARMACEUTICAL LIMITE | 396.42 Million INR | -376.037% |
| Ambalal Sarabhai Enterprises Limited | 1.74 Billion INR | -8.25% |
| Gennex Laboratories Limited | 867.14 Million INR | -117.624% |
| Denis Chem Lab Limited | 1.67 Billion INR | -12.447% |
| Colinz Laboratories Limited | 70.29 Million INR | -2584.523% |
| Godavari Drugs Limited | 1.56 Billion INR | -20.419% |
| Zenotech Laboratories Limited | 368.08 Million INR | -412.678% |
| Shree Ganesh Remedies Limited | 1.25 Billion INR | -49.895% |
| Bharat Parenterals Limited | 2.59 Billion INR | 27.253% |
| Coral Laboratories Limited | 836.6 Million INR | -125.568% |
| Evoq Remedies Limited | 63.09 Million INR | -2891.143% |
| Kerala Ayurveda Limited | 1.02 Billion INR | -84.403% |
| KOBO BIOTECH LIMITED | - INR | -Infinity% |
| Natural Capsules Limited | 1.55 Billion INR | -21.42% |
| Auro Laboratories Limited | 526.99 Million INR | -258.088% |